Cargando…
Serotonin syndrome in the acute treatment landscape of migraine: the lasmiditan experience
BACKGROUND: Serotonin syndrome (SS) symptoms overlap with adverse events associated with lasmiditan, a 5-HT (serotonin)(1F) receptor agonist for acute treatment of migraine. Because SS symptoms are heterogeneous, diagnosis can be challenging, and potential cases observed with lasmiditan treatment le...
Autores principales: | Blumenfeld, Andrew, Tepper, Stewart J., Khanna, Rashna, Doty, Erin, Vincent, Maurice, Miller, Sheila I. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10641788/ https://www.ncbi.nlm.nih.gov/pubmed/37965170 http://dx.doi.org/10.3389/fneur.2023.1291102 |
Ejemplares similares
-
Pharmacokinetics, Safety, and Tolerability of Lasmiditan in Pediatric Patients with Migraine
por: Tsai, Max, et al.
Publicado: (2021) -
Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks
por: Tepper, Stewart J., et al.
Publicado: (2020) -
Efficacy of lasmiditan for the acute treatment of perimenstrual migraine
por: MacGregor, E Anne, et al.
Publicado: (2022) -
Lasmiditan for acute treatment of migraine in patients with cardiovascular risk factors: post-hoc analysis of pooled results from 2 randomized, double-blind, placebo-controlled, phase 3 trials
por: Shapiro, Robert E., et al.
Publicado: (2019) -
The potential of lasmiditan in migraine
por: Mecklenburg, Jasper, et al.
Publicado: (2020)